Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol. Lancet Oncol. 2020 12; 21(12):1589-1601.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Clinical Decision-Making
Disease Progression
Female
High-Throughput Nucleotide Sequencing
Humans
Lung Neoplasms
Male
Middle Aged
Molecular Targeted Therapy
Neoplasm Recurrence, Local
Neoplasm Staging
Precision Medicine
Predictive Value of Tests
Time Factors
Young Adult

authors with profiles

Everett E. Vokes